Neoantigens
Neoantigens: are antigens encoded by tumor-specific mutated genes. Studies in the past few years have suggested a key role for neoantigens in cancer immunotherapy.
What's Popular in Neoantigens
-
OCT 11, 2020Cancer
OCT 11, 2020Neoantigens are extremely small biomarkers forming from cancer mutations that demonstrate the presence of cancerous cell ...WRITTEN BY: Kathryn DeMuth SullivanNOV 27, 2018Immunology
NOV 27, 2018Researchers utilize blood samples to determine cancer neoantigens to create effective vaccination in mouse modelWRITTEN BY: Nicholas BreehlJUL 10, 2017Clinical & Molecular DX
JUL 10, 2017In a rare scientific double-whammy, two groups of scientists independently found that targeted, personalized vaccines st ...WRITTEN BY: Xuan PhamDEC 29, 2016Immunology
DEC 29, 2016Nanodiscs just 10 nanometers wide successfully delivered customized cancer treatments to mice with colon and melanoma tu ...WRITTEN BY: Kara MarkerAPR 06, 2015Cancer
APR 06, 2015Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients' t ...WRITTEN BY: Ilene Schneider
OCT 11, 2020
Cancer
OCT 11, 2020
Neoantigens are extremely small biomarkers forming from cancer mutations that demonstrate the presence of cancerous cell
...
WRITTEN BY:
Kathryn DeMuth Sullivan
NOV 27, 2018
Immunology
NOV 27, 2018
Researchers utilize blood samples to determine cancer neoantigens to create effective vaccination in mouse model
WRITTEN BY:
Nicholas Breehl
JUL 10, 2017
Clinical & Molecular DX
JUL 10, 2017
In a rare scientific double-whammy, two groups of scientists independently found that targeted, personalized vaccines st
...
WRITTEN BY:
Xuan Pham
DEC 29, 2016
Immunology
DEC 29, 2016
Nanodiscs just 10 nanometers wide successfully delivered customized cancer treatments to mice with colon and melanoma tu
...
WRITTEN BY:
Kara Marker
APR 06, 2015
Cancer
APR 06, 2015
Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients' t
...
WRITTEN BY:
Ilene Schneider
APR 03, 2015
Cancer
APR 03, 2015
Cancer treatments that harness the body's immune system to wipe out tumors have begun paying off for some patients for w
...
WRITTEN BY:
Will Hector
-
C.E. CREDITS
NCI estimates that cancer will be the leading cause of death in 2030, worldwide. Checkpoint inhibitors and adoptive cell therapies (ACTs) cost up to ~$2 million/patient and have shown durabl...Speaker: Maithreyan SrinivasanPresented at: Immuno-Oncology 2020OCT 10, 2019 12:00 PM PDTC.E. CREDITS
OCT 10, 2019 12:00 PM PDTTumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...Speaker: Ravindra Kolhe, MD, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: QIAGENFEB 22, 2018 6:00 AM PST
FEB 22, 2018 6:00 AM PSTVaccibody has developed a unique platform technology able to substantially potentiate vaccines by an inherent mechanism that attract, activate and deliver antigens to antigen presenting cells...Speaker: Agnete Fredriksen, MSc, PhDPresented at: Drug Discovery 2018
C.E. CREDITS
NCI estimates that cancer will be the leading cause of death in 2030, worldwide. Checkpoint inhibitors and adoptive cell therapies (ACTs) cost up to ~$2 million/patient and have shown durabl...
Speaker:
Maithreyan Srinivasan
Presented at: Immuno-Oncology 2020
OCT 10, 2019
12:00 PM PDT
C.E. CREDITS
OCT 10, 2019
12:00 PM PDT
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
Speaker:
Ravindra Kolhe, MD, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: QIAGEN
FEB 22, 2018
6:00 AM PST
FEB 22, 2018
6:00 AM PST
Vaccibody has developed a unique platform technology able to substantially potentiate vaccines by an inherent mechanism that attract, activate and deliver antigens to antigen presenting cells...
Speaker:
Agnete Fredriksen, MSc, PhD
Presented at: Drug Discovery 2018
-
OCT 13, 2020 1:00 PM CEST
OCT 13, 2020 1:00 PM CESTThe Power of Omics is a three-day Thermo Fisher Scientific virtual event that focuses on harnessing the power of omics to advance scientific research. The virtual event will feature a series...SEP 23, 2020 6:00 AM PDT
SEP 23, 2020 6:00 AM PDTPlease join us at the 9th Annual Fluidigm Mass Cytometry Virtual Summit This yearly international meeting of the mass cytometry community is designed for new and experienced users, as well a...JUL 07, 2020 6:00 AM PDT
JUL 07, 2020 6:00 AM PDTFluidigm Infectious Disease and Oncology Virtual Summit Fluidigm technologies are integral to supporting current progress in cancer, immunology and infectious disease research. Fluidigm has...APR 29, 2020 6:00 AM PDT
APR 29, 2020 6:00 AM PDTLuminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...FEB 21, 2018 6:00 AM PST
FEB 21, 2018 6:00 AM PSTDespite the rapid pace of scientific advances that garner a better understanding of a myriad of diseased on their molecular level, modern drug discovery is a long, complex process. While on t...
OCT 13, 2020
1:00 PM CEST
OCT 13, 2020
1:00 PM CEST
The Power of Omics is a three-day Thermo Fisher Scientific virtual event that focuses on harnessing the power of omics to advance scientific research. The virtual event will feature a series...
SEP 23, 2020
6:00 AM PDT
SEP 23, 2020
6:00 AM PDT
Please join us at the 9th Annual Fluidigm Mass Cytometry Virtual Summit This yearly international meeting of the mass cytometry community is designed for new and experienced users, as well a...
JUL 07, 2020
6:00 AM PDT
JUL 07, 2020
6:00 AM PDT
Fluidigm Infectious Disease and Oncology Virtual Summit Fluidigm technologies are integral to supporting current progress in cancer, immunology and infectious disease research. Fluidigm has...
APR 29, 2020
6:00 AM PDT
APR 29, 2020
6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
FEB 21, 2018
6:00 AM PST
FEB 21, 2018
6:00 AM PST
Despite the rapid pace of scientific advances that garner a better understanding of a myriad of diseased on their molecular level, modern drug discovery is a long, complex process. While on t...
- Infusion
- Surgery
- Glioma
- Immune System
- Clinical Genetics
- Exome Sequencing
- Tumor
- T-Cells
- University
- Vaccine Research
- Vaccinations
- Dendritic Cells
- Cancer
- Clinical Medicine
- Health
- Gene
- Publishing
- Therapy
- Cell
- Sequencing
- Personality
- Research
- Immunity
- Immunotherapy
- Nerve
- Lymphocytes
- Research and Development
- CAR T-Cells
- Science
- Animal Research
- Human Genetics
- Molecular Genetics
- Disease
- Drug Safety
- Sequence Analysis
- Animals
- Drug Design
- Melanoma
- Immunology
- Genetics
- Vaccine
- Lung Cancer
- Protein
- T Cell
- Treatment of Cancer
- One Health
- Clinical Trials
- Brain
- Cancer Treatment
- ALS